Solvotrin irons out global mineral deficiencies
The company has since grown rapidly, doubling from seven to 15 employees in the past year, and will expand to 20 staff members by early next year
Irish pharma company Solvotrin Therapeutics is seeking €500,000 in EIIS funding as it ramps up sales of its Active Iron supplements into international markets.
Former Ernst & Young Entrepreneur of the Year finalist Pat O’Flynn, along with pharmaceutical chemist Professor John Gilmer and clinician, entrepreneur and expert adviser to the Irish Medicines Board Dr Mark Ledwidge, established Solvotrin in 2010 as a spin-out from Trinity College Dublin and launched their first product range last year....
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Interxion-DLR provides data centres for the support of active Public Cloud platforms
‘there is a planned change to hybrid IT by many customer’ says Seamus Matthews, Director of Enterprise Sales, Director of Enterprise Sales DLR